Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Diffuse Large B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Hongming He) · 13799361913
  • Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China

    Contact: Study coordinator (Junfeng Jiang) · 13893332604
  • The Fifth Affiliated Hospital of Guangzhou Medical University., Guangzhou, Guangdong, China

    Contact: Study coordinator (Runhui Zheng) · 13560225061
  • The Affiliated Hospital of Guangdong Medical University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Xinggui Chen) · baisr@sysucc.org.cn · 13652859129
  • Shenzhen People's Hospital, Shenzhen, Guangdong, China

    Contact: Study coordinator (Jihao Zhou) · 18718678693
  • The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China

    Contact: Study coordinator (Nan Chen) · 13631270598
  • Guangxi Zhuang Autonomous Region Cancer Hospital, Guilin, Guangxi, China

    Contact: Study coordinator (Hong Cen) · 13507711671
  • Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China

    Contact: Study coordinator (Qingfang Zeng) · 13870711700
  • Jiangxi Provincial Cancer Hospital, Nanchang, Jiangxi, China

    Contact: Study coordinator (Wuping Li) · 13870659916
  • Beijing Tongren Hospital, Beijing, China

    Contact: Study coordinator (Liang Wang) · 15001108693